Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 2 boards, counting each seat separately. Longest: Kyntra Bio Inc., 3 years.
Kyntra Bio Inc.
Director
Alnylam Pharmaceuticals Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 9, 2023 | Kyntra Bio Inc. | Open-market sale | −1,766 | $16.75 | $29,581 |
| Jun 9, 2023 | Kyntra Bio Inc. | Open-market sale | −2,178 | $17.51 | $38,137 |
| Jun 7, 2023 | Kyntra Bio Inc. | Grant or award | +8,289 | — | — |
Questions about Benjamin Cravatt
What boards is Benjamin Cravatt on?
Benjamin Cravatt sits on the boards of Alnylam Pharmaceuticals Inc. and Kyntra Bio Inc.
How long has Benjamin Cravatt served on boards?
Our records show at least 4 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.